Sumant Ramachandra

2013

In 2013, Sumant Ramachandra earned a total compensation of $2.6M as Former President, Research and Development at Synta Pharmaceuticals.

Compensation breakdown

Option Awards$1,732,860
Salary$109,230
Stock Awards$719,250
Other$1,800
Total$2,563,140

Ramachandra received $1.7M in option awards, accounting for 68% of the total pay in 2013.

Ramachandra also received $109.2K in salary, $719.3K in stock awards and $1.8K in other compensation.

Rankings

In 2013, Sumant Ramachandra's compensation ranked 3,046th out of 12,286 executives tracked by ExecPay. In other words, Ramachandra earned more than 75.2% of executives.

ClassificationRankingPercentile
All
3,046
out of 12,286
75th
Division
Manufacturing
1,020
out of 4,612
78th
Major group
Chemicals And Allied Products
267
out of 1,462
82nd
Industry group
Drugs
181
out of 1,156
84th
Industry
Pharmaceutical Preparations
150
out of 890
83rd
Source: SEC filing on April 30, 2014.

Ramachandra's colleagues

We found five more compensation records of executives who worked with Sumant Ramachandra at Synta Pharmaceuticals in 2013.

2013

Safi Bahcall

Synta Pharmaceuticals

Chief Executive Officer

2013

Vojo Vukovic

Synta Pharmaceuticals

Chief Medical Officer

2013

Amar Singh

Synta Pharmaceuticals

Former Senior Vice President, Chief Business Officer

2013

Keith Ehrlich

Synta Pharmaceuticals

Chief Financial Officer

2013

Steven Bernitz

Synta Pharmaceuticals

Senior Vice President, Chief Business Officer

In-depth

You may also like